Technology

ProteoCell’s platform is based on providing the best in vitro expression system for your recombinant product. Our priority is not pushing a specific cell line but rather working with you to identify the best expression system for your recombinant drug needs. We are equally versed with bacterial, yeast, and mammalian expression systems. Once this is selected, then ProteoCell continues to develop the optimal custom bioprocess platform for your product. By combining cell line development with bioprocess development, ProteoCell is able to screen the best, most stable, and most productive recombinant clone with the optimal bioprocess to produce it. This work package can be completed in a combined period of less than six months for both cell line development and bioprocess development for a mammalian cell line. ProteoCell also has capabilities to develop yeast and bacterial cell line based bioprocess platforms.